Is there evidence to support the use of constraint-induced therapy to improve the quality or quantity of upper extremity function of a 2 1/2-year-old girl with congenital hemiparesis? If so, what are the optimal parameters of this intervention?
Ries
Julie D
JD
Physical Therapy Program, Marymount University, Arlington, VA, USA.
Leonard
Rebecca
R
D000328:Adult; D000367:Age Factors; D001132:Arm / Q000502:physiology; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000627:therapeutic use; D002547:Cerebral Palsy / Q000534:rehabilitation*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003627:Data Interpretation, Statistical; D019992:Databases as Topic; D019317:Evidence-Based Medicine; D026241:Exercise Movement Techniques; D005260:Female; D006801:Humans; D007223:Infant; D009465:Neuromuscular Agents / Q000008:administration & dosage / Q000627:therapeutic use; D009989:Orthotic Devices; D010291:Paresis / Q000151:congenital* / Q000503:physiopathology / Q000534:rehabilitation*; D026741:Physical Therapy Modalities; D016032:Randomized Controlled Trials as Topic; D016059:Range of Motion, Articular; D016896:Treatment Outcome
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A